196 related articles for article (PubMed ID: 10726961)
1. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
[TBL] [Abstract][Full Text] [Related]
2. Effect of terlipressin on blood volume distribution in patients with cirrhosis.
Kiszka-Kanowitz M; Henriksen JH; Hansen EF; Møller S; Bendtsen F
Scand J Gastroenterol; 2004 May; 39(5):486-92. PubMed ID: 15180188
[TBL] [Abstract][Full Text] [Related]
3. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
5. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A
Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
[TBL] [Abstract][Full Text] [Related]
6. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
9. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
15. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
[TBL] [Abstract][Full Text] [Related]
17. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
Romero G; Kravetz D; Argonz J; Bildozola M; Suarez A; Terg R
J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
[TBL] [Abstract][Full Text] [Related]
18. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats.
Asfar P; Pierrot M; Veal N; Moal F; Oberti F; Croquet V; Douay O; Gallois Y; Saumet JL; Alquier P; Calès P
Crit Care Med; 2003 Jan; 31(1):215-20. PubMed ID: 12545018
[TBL] [Abstract][Full Text] [Related]
19. Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation.
Fayed N; Refaat EK; Yassein TE; Alwaraqy M
J Crit Care; 2013 Oct; 28(5):775-82. PubMed ID: 23618777
[TBL] [Abstract][Full Text] [Related]
20. Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs.
Hansen EF; Strandberg C; Højgaard L; Madsen J; Henriksen JH; Schroeder TV; Becker U; Bendtsen F
J Hepatol; 1999 Mar; 30(3):503-10. PubMed ID: 10190736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
